These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 10883717)

  • 1. Early detection of Alzheimer's disease using the Cambridge Cognitive Examination (CAMCOG).
    Schmand B; Walstra G; Lindeboom J; Teunisse S; Jonker C
    Psychol Med; 2000 May; 30(3):619-27. PubMed ID: 10883717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between memory complaints and incident Alzheimer's disease in elderly people with normal baseline cognition.
    Geerlings MI; Jonker C; Bouter LM; Adèr HJ; Schmand B
    Am J Psychiatry; 1999 Apr; 156(4):531-7. PubMed ID: 10200730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of cognitive decline in Alzheimer's disease and mild cognitive impairment using the CAMCOG: a five-year follow-up.
    Conde-Sala JL; Garre-Olmo J; Vilalta-Franch J; Llinàs-Reglà J; Turró-Garriga O; Lozano-Gallego M; Hernández-Ferrándiz M; Pericot-Nierga I; López-Pousa S
    Int Psychogeriatr; 2012 Jun; 24(6):948-58. PubMed ID: 22278151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accurate prediction of histologically confirmed Alzheimer's disease and the differential diagnosis of dementia: the use of NINCDS-ADRDA and DSM-III-R criteria, SPECT, X-ray CT, and APO E4 medial temporal lobe dementias. The Oxford Project to Investigate Memory and Aging.
    Jobst KA; Barnetson LP; Shepstone BJ
    Int Psychogeriatr; 1997; 9 Suppl 1():191-222; discussion 247-52. PubMed ID: 9447442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early onset Alzheimer's disease is associated with a distinct neuropsychological profile.
    Smits LL; Pijnenburg YA; Koedam EL; van der Vlies AE; Reuling IE; Koene T; Teunissen CE; Scheltens P; van der Flier WM
    J Alzheimers Dis; 2012; 30(1):101-8. PubMed ID: 22366769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conversion of amnestic Mild Cognitive Impairment to dementia of Alzheimer type is independent to memory deterioration.
    Rozzini L; Chilovi BV; Conti M; Bertoletti E; Delrio I; Trabucchi M; Padovani A
    Int J Geriatr Psychiatry; 2007 Dec; 22(12):1217-22. PubMed ID: 17562522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
    Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S
    Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The detection of dementia and cognitive impairment in a community population of elderly people with Parkinson's disease by use of the CAMCOG neuropsychological test.
    Hobson P; Meara J
    Age Ageing; 1999 Jan; 28(1):39-43. PubMed ID: 10203203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preclinical AD predicts decline in memory and executive functions in subjective complaints.
    van Harten AC; Smits LL; Teunissen CE; Visser PJ; Koene T; Blankenstein MA; Scheltens P; van der Flier WM
    Neurology; 2013 Oct; 81(16):1409-16. PubMed ID: 24049134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical utility of the K-T cancellation test in a memory clinic population.
    Wu YH; de Rotrou J; Sikkes SA; Rigaud AS; Plichart M
    J Clin Exp Neuropsychol; 2016 Dec; 38(10):1094-102. PubMed ID: 27349139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Executive dysfunction correlates with impaired functional status in older adults with varying degrees of cognitive impairment.
    Pereira FS; Yassuda MS; Oliveira AM; Forlenza OV
    Int Psychogeriatr; 2008 Dec; 20(6):1104-15. PubMed ID: 18752698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting risk of 2-year incident dementia using the CAMCOG total and subscale scores.
    Restaino M; Matthews FE; Minett T; Albanese E; Brayne C; Stephan BC
    Age Ageing; 2013 Sep; 42(5):649-53. PubMed ID: 23872637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Memory evaluation with a new cued recall test in patients with mild cognitive impairment and Alzheimer's disease.
    Ivanoiu A; Adam S; Van der Linden M; Salmon E; Juillerat AC; Mulligan R; Seron X
    J Neurol; 2005 Jan; 252(1):47-55. PubMed ID: 15654553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors that predict cognitive decline in patients with subjective cognitive impairment.
    Fonseca JA; Ducksbury R; Rodda J; Whitfield T; Nagaraj C; Suresh K; Stevens T; Walker Z
    Int Psychogeriatr; 2015 Oct; 27(10):1671-7. PubMed ID: 25812703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive assessment of a representative community population with Parkinson's disease (PD) using the Cambridge Cognitive Assessment-Revised (CAMCOG-R).
    Athey RJ; Porter RW; Walker RW
    Age Ageing; 2005 May; 34(3):268-73. PubMed ID: 15863411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accuracy of praxis test from Cambridge Cognitive Examination (CAMCOG) for Alzheimer's disease: a cross-sectional study.
    Cecato JF; Melo BAR; Moraes GC; Martinelli JE; Montiel JM
    Sao Paulo Med J; 2018; 136(5):390-397. PubMed ID: 30570090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detecting prodromal Alzheimer's disease in mild cognitive impairment: utility of the CAMCOG and other neuropsychological predictors.
    Gallagher D; Mhaolain AN; Coen R; Walsh C; Kilroy D; Belinski K; Bruce I; Coakley D; Walsh JB; Cunningham C; Lawlor BA
    Int J Geriatr Psychiatry; 2010 Dec; 25(12):1280-7. PubMed ID: 21086538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Clock Drawing Test for dementia of the Alzheimer's type: A comparison of three scoring methods in a memory disorders clinic.
    Brodaty H; Moore CM
    Int J Geriatr Psychiatry; 1997 Jun; 12(6):619-27. PubMed ID: 9215942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The accuracy of the Clock Drawing Test compared to that of standard screening tests for Alzheimer's disease: results from a study of Brazilian elderly with heterogeneous educational backgrounds.
    Aprahamian I; Martinelli JE; Neri AL; Yassuda MS
    Int Psychogeriatr; 2010 Feb; 22(1):64-71. PubMed ID: 19814841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of responders and reactive domains to rivastigmine in Alzheimer's disease.
    Frankfort SV; Appels BA; de Boer A; Tulner LR; van Campen JP; Koks CH; Beijnen JH; Schmand BA
    Pharmacoepidemiol Drug Saf; 2007 May; 16(5):545-51. PubMed ID: 17109476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.